Active ingredientBexaroteneCat. No. P-B071-001CAS 153559-49-0Family · Pharmaceutical analytical standards
Bexarotene
A third-generation retinoid that selectively activates retinoid X receptors (RXR), approved in the United States in 1999 to treat the skin lesions of cutaneous T-cell lymphoma. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?In a University of Cambridge study in multiple sclerosis it stimulated repair of myelin, the sheath that wraps the nerves, although it has not become a treatment for this disease.
Go to the active ingredient →Active ingredientBexaroteneCat. No. P-B071-001CAS 153559-49-0
MetaboliteBexarotene Acyl GlucuronideCat. No. P-B071-002CAS 198700-33-3
Isotopically labelledBexarotene-d4Cat. No. P-B071-003CAS 2182068-00-2
Impurity1-Ethyl-1,3,3,5-tetramethyl-2H-indeneCat. No. P-B071-004CAS 29641-87-0
Impurity2,5-Dimethyl-2,5-hexanediolCat. No. P-B071-005CAS 110-03-2
Impurity2,5-Dimethyl-3-hexyne-2,5-diolCat. No. P-B071-006CAS 142-30-3
Impurity6-Hydroxy BexaroteneCat. No. P-B071-007CAS 368451-07-4
Impurity6-oxo-BexaroteneCat. No. P-B071-008CAS 368451-13-2
Impurity7-Hydroxy BexaroteneCat. No. P-B071-009CAS 368451-10-9
Impurity7-Oxo BexaroteneCat. No. P-B071-010CAS 368451-15-4
ImpurityBexarotene Impurity 1Cat. No. P-B071-011CAS 2840408-54-8
ImpurityBexarotene Impurity 2Cat. No. P-B071-012CAS 1349659-55-7
ImpurityBexarotene Impurity 3Cat. No. P-B071-016CAS 2841325-17-3
ImpurityBexarotene Impurity 4Cat. No. P-B071-018CAS 2825537-35-5
ImpurityBexarotene Impurity 5Cat. No. P-B071-019
ImpurityBexarotene Impurity 6Cat. No. P-B071-020CAS 153559-48-9
ImpurityBexarotene Impurity 7Cat. No. P-B071-021CAS 153559-45-6
ImpurityBexarotene Impurity 8Cat. No. P-B071-022
ImpurityBexarotene Impurity 9Cat. No. P-B071-023
ImpurityBexarotene Tetrahydro Naphthalene ImpurityCat. No. P-B071-025CAS 6683-48-3
Impuritycis-2,5-Dimethyl-3-hexene-2,5-diolCat. No. P-B071-026CAS 6117-86-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.